Professor Mike Baxter, Diabetes Therapy Lead Sanofi Medical

I have a background in Biochemistry (BsC and PhD), immunology (BMedSci) and medicine (BM,BS). I am a Fellow of the Royal College of Physicians (FRCP)

I was a consultant diabetologist, endocrinologist and general physician at an acute trust for 30 years.

During this time I was also Clinical Director of Medicine (7 years), Medical Director of the Trust (10 years) and Deputy CEO (5 years). My major achievement was the successful application of the organisation for Foundation Status awarded post Mid Staffs and with increased scrutiny on organisation provision of clinical governance.

I stepped down from my NHS clinical role in 2012 but I am currently an NHS NED at ASPH (5 years) and Frimley health (9 months) were I make an active contribution at board and committee level with a focus on patient and staff outcomes, safety and experience. I aspire to become and acute Trust Chair.

I have recently been appointed as an honorary Professor (medicine) at the University of Swansea where I have designed and deliver a course on aspects of diabetes.

I have worked with sanofi since 2012 and have been involved with data generation, publications and more recently a seconded post working with the Japanese affiliate in launching a new diabetes therapy.

I have been active in research and publications throughout my career and since 1978 to date have published in excessive of 100 peer reviewed papers and reviews and an undergraduate texted on biochemistry for medical students. The topics of my research range through basic medical science, clinical studies and medical politics.

I remain committed to teaching, data generation and research all aimed at providing improved patient outcomes and experience.

Quality In Care Diabetes

  • 2020 KEY DATES
  • Open for entry: Wednesday 18 March 2020
  • Entry deadline: Monday 20 July 2020
  • Judging day: Thursday 10 September 2020
  • Awards ceremony: Thursday 15 October 2020
QiC Diabetes is partnered by:
Supported by: